Biocartis Group NV
XBRU:BCART
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Biocartis Group NV
Income from Continuing Operations
Biocartis Group NV
Income from Continuing Operations Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Biocartis Group NV
XBRU:BCART
|
Income from Continuing Operations
-€67.9m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
N/A
|
|
|
Nyxoah SA
XBRU:NYXH
|
Income from Continuing Operations
-€90.1m
|
CAGR 3-Years
-42%
|
CAGR 5-Years
-49%
|
CAGR 10-Years
N/A
|
|
|
Ion Beam Applications SA
XBRU:IBAB
|
Income from Continuing Operations
€12.8m
|
CAGR 3-Years
28%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
N/A
|
|
|
Sequana Medical NV
XBRU:SEQUA
|
Income from Continuing Operations
-€51.9m
|
CAGR 3-Years
-25%
|
CAGR 5-Years
-25%
|
CAGR 10-Years
N/A
|
|
Biocartis Group NV
Glance View
Biocartis Group NV which engages in the development of oncology molecular diagnostic solutions. The company is headquartered in Malines (Mechelen), Antwerpen and currently employs 619 full-time employees. The company went IPO on 2015-04-27. The group has the Idylla system to deliver results within a period of between 35 to 150 minutes.
See Also
What is Biocartis Group NV's Income from Continuing Operations?
Income from Continuing Operations
-67.9m
EUR
Based on the financial report for Jun 30, 2023, Biocartis Group NV's Income from Continuing Operations amounts to -67.9m EUR.
What is Biocartis Group NV's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 5Y
-11%
Over the last year, the Income from Continuing Operations growth was -8%. The average annual Income from Continuing Operations growth rates for Biocartis Group NV have been -1% over the past three years , -11% over the past five years .
